Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Johnson & Johnson's Stock Reasonable by the Numbers?
Motley Fool
Sunday, April 29, 2012 - 12:30pm
tags:
JNJ
4 Biotech Stocks To Acquire Now For Gains In 2013
Seeking Alpha
Sunday, April 29, 2012 - 12:27pm
tags:
Dendreon, Jazz Pharmaceuticals, Cell Therapeutics, Human Genome Sciences
Glaxo Bid Undervalues Human Genome Sciences, Sunday Times Says
Bloomberg
Sunday, April 29, 2012 - 12:26pm
tags:
GSK, Human Genome Sciences
China Biotech In Review: A Week Of Big Deals
Seeking Alpha
Sunday, April 29, 2012 - 12:25pm
tags:
Watson, Renhe Pharmacy, SK Biopharmaceuticals, Hanmi Pharm, S*Bio
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Pharmabiz
Saturday, April 28, 2012 - 1:40pm
tags:
Watson Pharmaceuticals, Antares Pharma, Gelnique, overactive bladder
Turning Elan around
Irish Independent, Ireland
Saturday, April 28, 2012 - 1:12pm
tags:
Elan
Covidien fiscal 2Q profit climbs 9 percent
BusinessWeek
Saturday, April 28, 2012 - 1:10pm
tags:
Covidien, earnings
FDA approves Levaquin to combat pneumonic plague bioterrorist attack
MedCity News
Saturday, April 28, 2012 - 1:08pm
tags:
Levaquin, pneumonic plague
Watson Creates Third-Largest Generic-Drug Company With Actavis Buy
FDA News
Saturday, April 28, 2012 - 1:06pm
tags:
Watson Pharmaceuticals, M&A, generics
3 Healthcare Companies Poised For A Short-Term Pop
Seeking Alpha
Saturday, April 28, 2012 - 1:03pm
tags:
USANA Health Sciences, Codexis, Watson Pharmaceuticals
Ex-Principal Wins $4 Million Verdict Against Drug Maker
Connecticut Law Tribune
Saturday, April 28, 2012 - 1:00pm
tags:
Wyeth, Prempro, lawsuits, Pfizer
Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
4-Traders
Saturday, April 28, 2012 - 12:57pm
tags:
Nymox, NX-1207, benign prostatic hyperplasia, BPH
Sanofi first quarter profit climbs 13% on Genzyme, Lantus
The Star Ledger, NJ
Saturday, April 28, 2012 - 12:55pm
tags:
Sanofi, earnings
Novo Nordisk Finally Looks (Slightly) Mortal
Seeking Alpha
Saturday, April 28, 2012 - 12:54pm
tags:
Novo Nordisk
Plant-Made Pharmaceuticals And The Democratization Of Health Care
Seeking Alpha
Saturday, April 28, 2012 - 12:52pm
tags:
iBio
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Pharmalive
Saturday, April 28, 2012 - 12:50pm
tags:
ONYX Pharmaceuticals, Carfilzomib, Multiple Myeloma
Threshold Pharmaceuticals: TH-302 Phase IIb Clinical Results In First-Line Pancreatic Cancer
Seeking Alpha
Saturday, April 28, 2012 - 12:43pm
tags:
TH-302, pancreatic cancer, Threshold Pharmaceuticals
Merck's Q1 Results Mixed; All Eyes On Drug Pipeline
Yahoo/Investors
Saturday, April 28, 2012 - 12:34pm
tags:
Merck, earnings
Merck Wins U.S. ZETIA® (ezetimibe)/ VYTORIN® (ezetimibe/simvastatin) Patent Infringement Lawsuit
Yahoo/BusinessWire
Saturday, April 28, 2012 - 12:29pm
tags:
Merck, Zetia, lawsuits, patents, Mylan, generics
Sanofi-Aventis's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Seeking Alpha
Saturday, April 28, 2012 - 12:28pm
tags:
Sanofi, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.